Filing Details
- Accession Number:
- 0001209191-18-026609
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-27 16:38:22
- Reporting Period:
- 2018-04-25
- Accepted Time:
- 2018-04-27 16:38:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661567 | Michael Parini | 50 Northern Avenue Boston MA 02210 | Evp, Cl&Ao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-04-25 | 2,125 | $90.29 | 42,123 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-04-25 | 2,214 | $155.07 | 39,909 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-25 | 300 | $156.36 | 39,609 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-04-26 | 38,250 | $122.45 | 77,859 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-04-26 | 38,250 | $159.56 | 39,609 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-04-25 | 2,125 | $0.00 | 2,125 | $90.29 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-04-26 | 38,250 | $0.00 | 38,250 | $122.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,125 | 2026-07-11 | No | 4 | M | Direct | |
| 29,750 | 2026-01-03 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $155.07 (range $154.61 to $155.56).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $156.36 (range $155.97 to $156.75).
- Open market sales reported on this line occurred at a weighted average price of $159.56 (range $159.51 to $159.60).
- The option vests in 16 quarterly installments from 7/12/2016.
- The option vests in 16 quarterly installments from 1/4/2016.
Billionaire Hedge Funds
